Articles By Gregory McDermott, MD
SARD-ILD: Significant diagnostic and treatment delays
Should we be screening all our patients with systemic autoimmune rheumatic disease (SARD) for interstitial lung disease?
Read Article
Should we be screening all our patients with systemic autoimmune rheumatic disease (SARD) for interstitial lung disease?
Read Article
Gregory McDermott is an Instructor of Medicine at Harvard Medical School and Attending Rheumatologist at Brigham and Women’s Hospital. His research interests include risk factors for rheumatoid arthritis-associated lung diseases and the use of genetics and other biomarkers to predict treatment response and disease outcomes in rheumatology.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
